Relationship between Obstructive Sleep Apnea Severity and Sleep, Depression and Anxiety Symptoms in Newly-Diagnosed Patients Authors: Paul M. Macey, Mary A. Woo, Rajesh Kumar, Rebecca L. Cross, Ronald M. Harper Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0010211 ABSTRACT Obstructive sleep apnea (OSA) occurs in at least 10% of the population, and leads to higher morbidity and mortality; however, relationships between OSA severity and sleep or psychological symptoms are unclear. Existing studies include samples with wide-ranging comorbidities, so we assessed relationships between severity of OSA and common sleep and psychological disturbances in recently diagnosed OSA patients with minimal co-morbidities. We studied 49 newly diagnosed, untreated OSA patients without major co-morbidities such as mental illness, cardiovascular disease, or stroke; subjects were not using psychoactive medications or tobacco (mean ± std age: 46.8±9.1 years; apnea/hyponea index [AHI]: 32.1±20.5 events/hour; female/male: 12/37; weight <125 kg). We evaluated relationships between the AHI and daytime sleepiness (Epworth Sleepiness Scale; ESS), sleep quality (Pittsburg Sleep Quality Index; PSQI), depressive symptoms (Beck Depression Inventory-II; BDI), and anxiety symptoms (Beck Anxiety Inventory; BAI), as well as sex and body mass index (BMI). AHI was similar in females and males. Mean levels of all symptoms were above normal thresholds, but AHI was not correlated with age, ESS, PSQI, BDI, or BAI; only BMI was correlated with OSA severity. No differences in mean AHI appeared when subjects were grouped by normal versus elevated values of ESS, PSQI, BDI, or BAI. Consistent with other studies, a strong link between OSA severity and psychological symptoms did not appear in these newly diagnosed patients, suggesting that mechanisms additional to the number and frequency of hypoxic events and arousals occurring with apneas contribute to adverse health effects in OSA. OSA patients presenting with mild or moderate severity, and no major co-morbidities will not necessarily have low levels of sleep or psychological disturbances. INTRODUCTION Obstructive sleep apnea (OSA) occurs in approximately 10% of the population, leads to physical and psychological co-morbidities, and is associated with higher all-cause mortality [1] , [2] , [3] , [4] . Symptoms of OSA include daytime sleepiness, poor sleep quality, and co-morbidities such as high levels of depressive symptoms and anxiety [5] , [6] , [7] , but the relationship between OSA severity and accompanying symptoms is weak. The severity of OSA, as defined by the American Academy of Sleep Medicine [4] , is classified by the number of partial or complete cessations of breathing per hour during sleep, the apnea/hypopnea index (AHI). However, most studies do not report strong relationships between AHI and severity of symptoms [8] , [9] . The extent to which a patient's reported AHI level predicts severity of symptoms remains unclear, and is the topic of recent investigations [10] , [11] , [12] , [13] . Excessive daytime sleepiness is the most common symptom associated with OSA [4] , [6] . High daytime sleepiness is often a primary reason for referring a person for a polysomnographic study, and the evidence of higher measures of daytime sleepiness in OSA is unequivocal [4] , [6] . Since OSA is defined according to a cut-off in AHI, a logical assumption is that higher AHI leads to higher daytime sleepiness. However, while some large samples show a statistically significant correlation, AHI and daytime sleepiness measures are not strongly correlated [9] , [13] , [14] , [15] , [16] , [17] , a pattern noted in the revised International Classifications of Sleep Disorders criteria [18] . Other symptoms that are present in persons with OSA also show only weak relationships with AHI. Poor sleep quality is common in people with OSA, but is not explained by AHI [19] , even though obstructive events are typically associated with arousals. Apneic indices fail to explain other characteristics: levels of depressive symptoms, while high in approximately half of OSA patients [5] , [20] , [21] , [22] , correlate at best poorly with AHI [10] , [23] , and similar findings are true for anxiety symptoms [24] , [25] , [26] . Mood and affect disturbances could arise from neural injury that occurs in the condition [27] , [28] , [29] , [30] , and such injury would be expected to be greater with increasing severity, since animal evidence shows that repeated hypoxic episodes lead to cellular injury and death in a dose-dependent fashion [31] , [32] , [33] , [34] . Existing studies mostly describe typical OSA populations that include patients with major risk factors for illness and co-morbidities, such as severe obesity, tobacco use, mental disorders, and major cardiovascular disease. Since these factors influence sleep and affective symptoms, it is possible that a stronger relationship between OSA severity and symptoms will be present in a sample of patients without major health issues other than OSA. Therefore, our objective was to describe relationships between severity of OSA and severity of common sleep and psychological disturbances present in the sleep disorder, in a sample with minimal co-morbidities. We studied recently-diagnosed, moderate to severe OSA patients with minimal comorbidities, who had not started treatment, and who did not have other major cardiovascular or psychiatric disorders. METHODS All procedures were approved by the UCLA Institutional Review Board, and all participants provided written, informed consent. We performed a cross-sectional study of OSA patients, diagnosed based on an overnight sleep study, who completed commonly-used questionnaires for evaluation of sleep and psychological symptoms. We studied 49 newly diagnosed, untreated OSA patients without major comorbidities ( Table 1 ). Subjects were recruited via the UCLA Sleep Disorders Laboratory. Patients were untreated for the sleep disorder, did not currently smoke, and were not taking psychiatric medications. Screening was by self-report on initial clinical interview prior to study onset. These subjects were originally recruited as part of a brain imaging study [28] , so inclusion criteria due to scanner limitations included a weight of less than 125 kg, no claustrophobia, and absence of metallic implants. Characteristics and symptoms of 49 OSA patients; BMI  =  body mass index; AHI  =  apnea/hypopnea index (severity of OSA); SaO 2  =  blood oxygen saturation (oximetry); REM  =  rapid eye movement sleep; ESS  =  Epworth Sleepiness Scale; PSQI  =  Pittsburgh Sleep Quality Index; BDI  =  Beck Depression Inventory II; BAI  =  Beck Anxiety Inventory; ACE  =  angiotensin-converting enzyme inhibitor; ARB  =  angiotensin receptor blocker; statin  =  cholesterol-lowering via inhibition of HMG-CoA reductase enzyme. *Missing data for N  =  38 subjects; years of education were not originally collected. Missing data points (indicates that one subject's value is missing, but not always the same subject); one subject missing for each of SaO 2 and position measurements due to technical failures, blood pressure medication history not collected for one subject; summary values are shown for the remaining 48 subjects. TABLE: Subject information. Characteristics Sex 12 ♀: 37 ♂ Mean St Dev Range Age (years) 46.8 ±9.1 31–63 BMI (kg/m 2 ) 30.4 ±5.1 21–43 Years Education * (N = 11) 19 ±3 16–25 Sleep AHI (events/hour) 32.1 ±20.5 5–101 SaO 2 nadir † 80.2 ±9.4 50–96 SaO 2 baseline † 94.9 ±1.9 88–97 Apnea type † N % Positional (supine) 8 17% REM-only 11 23% All-stage (non-specific) 29 60% Symptoms ESS 10.5 ±4.9 0–24 PSQI 9.3 ±4.2 0–20 BDI 9.7 ±8.8 0–37 BAI 11.2 ±12.1 0–54 Medical History N % Cardioascular disease (angina, atherosclerosis, cerebrovascular disease, coronary artery disease, heart failure, myocardial infarction) 0 0% Diabetes 5 10% Gout 2 4% Hypertension 17 35% Diagnosed Mental Health Disorder 0 0% Migraines 0 0% Sleep disorder (not OSA) 0 0% Stroke 0 0% Tobacco (past use) 8 16% Vascular congenital abnormality 0 0% Medications Anti-depressant (past use) 3 6% Anti-anxiety (past use) 1 2% Statin † 9 19% ACE/ARB † 6 13% DATA COLLECTION The OSA severity was determined based on an overnight sleep study. The AHI, or number of apnea/hypopnea per hour, was determined according to standard criteria [4] . We collected subject characteristics of age, sex and body mass index (BMI), as well as measures of sleep, depression and anxiety symptoms. All symptoms were assessed with commonly-used self-report questionnaires. Daytime sleepiness was measured with the Epworth Sleepiness Scale (ESS), sleep quality by the Pittsburgh Sleep Quality Index (PSQI), depressive symptoms with the Beck Depression Inventory II (BDI), and anxiety symptoms with the Beck Anxiety Inventory (BAI). These measures show moderate to strong validity and reliability in healthy people and in groups with medical conditions [35] , [36] , [37] , [38] , [39] , although OSA populations have not been assessed. STATISTICAL ANALYSIS The non-parametric Spearman's rho was calculated for AHI correlations with ESS, PSQI, BDI, BAI and BMI. Mean AHI values were compared between groups that were defined by classifying subjects into normal and elevated symptom levels, using independent samples t-tests. The standard p threshold of 0.05 was used. The 95% confidence intervals for Spearman's rho were calculated using a bootstrap method (500 samples). Correlations and independent samples t-tests were performed with the statistical software SPSS (Chicago, IL), and the confidence intervals were calculated with the bootstrap function in MATLAB 7.8 with the Statistics Toolbox (The Mathworks Inc., Natwick, MA). Power analyses were performed with G*Power 3 [40] . RESULTS The AHI, the “gold standard” of obstructive sleep apnea severity, was not significantly correlated with symptoms of daytime sleepiness, sleep quality, depression, or anxiety. Specifically, AHI showed no significant correlations with age, ESS, PSQI, BDI, or BAI ( Table 2 , 1 st column). Only BMI showed a significant positive correlation with AHI. Additionally, we found no group differences in mean AHI when subjects were categorized into two groups according to normal/elevated measures of each of ESS, PSQI, BDI, or BAI ( Table 3 ). We used a cutoff of >9 to classify BDI measures as high, a threshold lower than the typical 14, but a more sensitive level [41] , which we previously showed can predict additional neural injury in high relative to low BDI OSA patients [42] . The full correlation table showed additional significant relationships between all combinations of BDI, BAI and PSQI ( Table 2 ). Correlation table of subject characteristics, symptoms, and OSA severity; Spearman's rho, p value, and 95% confidence interval (CI) are shown for each correlation (* indicates significant). BMI  =  body mass index; AHI  =  apnea/hypopnea index (severity of OSA); ESS  =  Epworth Sleepiness Scale; PSQI  =  Pittsburgh Sleep Quality Index; BDI  =  Beck Depression Inventory II; BAI  =  Beck Anxiety Inventory. Mean AHI compared across groups of subjects classified according to symptom severity or sex, using independent samples t-tests; ESS  =  Epworth Sleepiness Scale; PSQI  =  Pittsburgh Sleep Quality Index; BDI  =  Beck Depression Inventory II; BAI  =  Beck Anxiety Inventory. TABLE: Correlations. Correlation table AHI Age BMI ESS PSQI BDI Characteristics Age r −0.06 p 0.67 CI [−0.33, 0.28] BMI r 0.33 * 0.07 p 0.002 0.63 CI [0.00, 0.57] [−0.29, 0.37] Symptoms ESS r −0.18 −0.16 0.04 p 0.21 0.28 0.80 CI [−0.47, 0.36] [−0.47, 0.11] [−0.26, 0.40] PSQI r 0.07 −0.20 0.12 0.08 p 0.61 0.16 0.40 0.56 CI [−0.21, 0.36] [−0.48, 0.07] [−0.16, 0.41] [−0.23, 0.34] BDI r 0.03 −0.18 0.13 0.20 0.74 * p 0.83 0.23 0.36 0.16 <0.001 CI [−0.25, 0.34] [−0.49, 0.15] [−0.16, 0.42] [−0.06, 0.50] [−0.57, 0.85] BAI r 0.09 0.02 0.21 0.24 0.47 * 0.72 * p 0.55 0.91 0.14 0.09 <0.001 <0.001 CI [−0.17, 0.38] [−0.28, 0.33] [−0.08, 0.48] [−0.04, 0.44] [−0.22, 0.67] [−0.54, 0.82] TABLE: Mean comparisons. AHI – Comparing means N Mean ± std N Mean ± std Diff se P Characteristics Female Male ♂ - ♀ Sex 12 24.3±18.8 37 34.1±19.7 9.9 6.3 0.8 Symptoms Cutoff Normal High High -Normal PSQI >5 7 22.7±13.0 42 33.2±20.3 10.5 5.8 0.2 ESS >9 19 32.2±14.8 30 31.4±22.5 −0.8 5.8 0.9 BDI >9 29 33.0±20.9 20 29.9±18.2 −3.1 5.6 0.6 BAI >7 26 28.9±16.5 23 34.9±22.7 6.1 5.7 0.2 POWER ANALYSIS A medium-to-large effect size, measured as Pearson's r , of 0.38 (0.34 one-tailed) would be required to detect any relationship with 80% power at α = 0.05 [40] . The largest symptom and AHI correlation effect size (non-parametric equivalent) found in this sample was 0.18 ( Table 2 , 1 st column). DISCUSSION A strong link between the standard measure of OSA severity, the AHI, and accompanying symptoms did not appear in these newly-diagnosed patients, who were untreated and without major co-morbid illness. However, the presence of OSA, diagnosed primarily based on AHI values, was associated with abnormally high levels of depressive and anxious symptoms, daytime sleepiness, and poor sleep quality. These findings suggest that mechanisms other than the number and frequency of hypoxic events contribute to adverse health effects in this patient population. As found in other OSA populations [11] , [43] , levels of daytime sleepiness, poor sleep quality, depression and anxiety were high, with mean levels of these symptoms above normal cutoff thresholds ( Table 3 ). Thus, the absence of correlation between symptoms and disease severity does not result from low levels of symptoms in this set of OSA patients. One possibility is that the population consists of several distinct subgroups, which are affected differently by the apneic periods. Variations in affective and mood symptoms in particular are likely to be associated with variations in a number of symptoms related to neural functioning, as we previously showed that, in subsets of the present 49 OSA patients, depressive symptoms are associated with brain structural changes, as are symptoms of anxiety [42] , [44] . Our neuroimaging findings show differential effects on brain structure of diabetes, sleep state in which apneas occur, and sex [45] , [46] , [47] . The heterogeneous nature of characteristics associated with brain changes in OSA suggests that these variables should be considered separately with regards to their influence on sleep and psychological symptoms; the present study did not have enough subjects to power such tests. The findings support the hypothesis that AHI is not the most appropriate polysomnographic measure of clinical impact of OSA, a relationship noted previously [48] , [49] . One possible reason is that AHI is based on numbers of all apneas and hypopneas, but not severity of apneic events. Symptoms like poor sleep quality and daytime sleepiness may be more closely related to number and extent of arousals, which are principally associated with obstructive apneas. The frequency of arousals is a better predictor of fatigue [8] , another common symptom of OSA [50] . Similarly, blood oxygen desaturation appears to be a better predictor than AHI of daytime sleepiness [51] and cardiovascular sequelae [52] , [53] . The problem of defining clinically-relevant operational definitions of sleep variables was part of the motivation for the development by the American Academy of Sleep Medicine of new scoring criteria in 2007 [54] , although it is unclear whether the new definitions of severity are better predictors of symptoms. The lack of strong correlations between AHI and subjective sleep symptoms suggests that factors other than respiratory events and arousal contribute to these disturbances. Affective disruptions appear to be closely related to sleep quality: the PSQI had the strongest correlations with the BDI and BAI, similar to a previous report [25] . While self-reports are potentially inaccurate, especially in psychologically disturbed populations, the PSQI has moderate to high validity and reliability [35] , with validation in other sleep-disturbed populations [55] . Determining the extent to which mood disruptions are independent of OSA is problematic, since several mental illnesses, including depression, are classified by symptoms that include sleep disturbances [56] . The BDI includes questions on symptoms that overlap typical OSA characteristics, such as sleepiness and fatigue, loss of libido, and impaired concentration. This overlap does not alter the depressive symptoms themselves but confounds interpretation of the source of the mood disturbances; we cannot disentangle the extent to which individuals with depressed mood experience a disorder independent of OSA. The DSM-IV criteria for organic rule-out of a primary mood disorder, i.e., diagnosis of a mood disorder that is secondary to a physical medical illness [57] , do not clarify whether depressed mood in OSA should be considered secondary to the physical disorder. Our earlier work demonstrating that mildly depressed or anxious OSA subjects show greater brain injury over patients with normal mood or affect suggests a neural basis for the mood disturbances [42] , [44] . However, whether OSA preceded the neural injury and mood symptoms cannot be determined in the present cross-sectional study. Limitations of the current study include the specific nature of the study population; a group with minimal co-morbidities, recent diagnosis, and limited BMI is not representative of the general OSA population. Furthermore, the heterogenous nature of the disorder, even within the restricted sample used here, means that a much larger number of subjects than 49 would need to be studied to verify that the findings generalize to a larger population. Additional limitations relate to the lack of objective measures of symptoms. However, the variables assessed in the present study reflect information typically available to, or easily collected by clinicians. More-accurate measurements may allow relationships between OSA severity and symptoms to be detected, but given the minimal effects found in this and other studies, it is unlikely that any strong correlation would appear using different measures. Other potential approaches to refining the analysis include increasing the number of subjects, or selecting a different OSA population. In particular, a possibility would be to study separate populations based on depression, sex, or sleep quality, to potentially elucidate relationships within those subgroups. A patient's reported OSA severity should not be assumed to directly relate to severity of accompanying psychological symptoms. These findings do not negate the importance of sleep-disordered breathing; many clinical symptoms are associated with sleep disturbances, and screening for the presence of sleep disorders, including OSA, is important [58] . The present results are limited to newly-diagnosed, untreated, middle-aged OSA patients without major co-morbid illness, and weighing less than 125 kg, so different patterns may appear in other OSA populations. Obesity (measured as BMI), a known risk factor for the sleep disorder, is associated with OSA severity, as is the most prominent co-morbidity, hypertension [12] , [59] . For patients who have received a sleep study, the presence of OSA of any severity would suggest that a patient likely has abnormally high levels of daytime sleepiness, depression, and anxiety, as well as poor sleep quality. For patients without an assessment for OSA, but presenting with sleepiness, depression, and complaints of poor sleep, the presence of OSA may be suspected, but the level of symptoms should not be assumed to relate to the severity of the sleep disorder. REFERENCES [1] Marshall NS Won KKH Liu PY Cullen SRJ Knuiman MW 2008 Sleep Apnea as an Independent Risk Factor for All-Cause Mortality: The Busselton Health Study. Sleep 31 1079 1085 [2] Young T Finn L Peppard PE Szklo-Coxe M Austin D 2008 Sleep Disordered Breathing and Mortality: Eighteen-Year Follow-up of the Wisconsin Sleep Cohort. Sleep and Biological Rhythms 31 1071 1078 [3] Shahar E Whitney CW Redline S Lee ET Newman AB 2001 Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 19 25 [4] 1999 Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 667 689 [5] Reynolds CF 3rd Kupfer DJ McEachran AB Taska LS Sewitch DE 1984 Depressive psychopathology in male sleep apneics. J Clin Psychiatry 45 287 290 [6] Seneviratne U Puvanendran K 2004 Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep Med 5 339 343 [7] Baldwin CM Griffith KA Nieto FJ O'Connor GT Walsleben JA 2001 The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 24 96 105 [8] Yue HJ Bardwell W Ancoli-Israel S Loredo JS Dimsdale JE 2009 Arousal frequency is associated with increased fatigue in obstructive sleep apnea. Sleep Breath [9] Johansson P Alehagen U Svanborg E Dahlstrom U Brostrom A 2009 Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 10 1005 1011 [10] Dominici M Gomes Mda M 2009 Obstructive sleep apnea (OSA) and depressive symptoms. Arq Neuropsiquiatr 67 35 39 [11] Ronksley PE Hemmelgarn BR Heitman SJ Hanly PJ Faris PD 2009 Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 64 834 839 [12] Thong JF Pang KP 2008 Clinical parameters in obstructive sleep apnea: are there any correlations? J Otolaryngol Head Neck Surg 37 894 900 [13] Koutsourelakis I Perraki E Bonakis A Vagiakis E Roussos C 2008 Determinants of subjective sleepiness in suspected obstructive sleep apnoea. J Sleep Res 17 437 443 [14] Bixler EO Vgontzas AN Lin HM Calhoun SL Vela-Bueno A 2005 Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90 4510 4515 [15] Sauter C Asenbaum S Popovic R Bauer H Lamm C 2000 Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome. J Sleep Res 9 293 301 [16] Roure N Gomez S Mediano O Duran J Pena Mde L 2008 Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med 9 727 731 [17] Duran J Esnaola S Rubio R Iztueta A 2001 Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163 685 689 [18] American Academy of Sleep Medicine 2005 International classification of sleep disorders: Diagnostic and coding manual. 2nd ed. Westchester, IL American Academy of Sleep Medicine [19] Kezirian EJ Harrison SL Ancoli-Israel S Redline S Ensrud K 2009 Behavioral correlates of sleep-disordered breathing in older men. Sleep 32 253 261 [20] Millman RP Fogel BS McNamara ME Carlisle CC 1989 Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 50 348 351 [21] Akashiba T Kawahara S Akahoshi T Omori C Saito O 2002 Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 122 861 865 [22] Vandeputte M de Weerd A 2003 Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 4 343 345 [23] McCall WV Harding D O'Donovan C 2006 Correlates of Depressive Symptoms in Patients With Obstructive Sleep Apnea. J Clin Sleep Med 2 [24] Borak J Cieslicki JK Koziej M Matuszewski A Zielinski J 1996 Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res 5 123 127 [25] Naismith S Winter V Gotsopoulos H Hickie I Cistulli P 2004 Neurobehavioral functioning in obstructive sleep apnea: differential effects of sleep quality, hypoxemia and subjective sleepiness. J Clin Exp Neuropsychol 26 43 54 [26] Saunamaki T Jehkonen M 2007 Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand 116 277 288 [27] Macey PM Henderson LA Macey KE Alger JR Frysinger RC 2002 Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med 166 1382 1387 [28] Macey PM Kumar R Woo MA Valladares EM Yan-Go FL 2008 Brain structural changes in obstructive sleep apnea. Sleep 31 967 977 [29] Yaouhi K Bertran F Clochon P Mezenge F Denise P 2009 A combined neuropsychological and brain imaging study of obstructive sleep apnea. J Sleep Res 18 36 48 [30] Morrell MJ McRobbie DW Quest RA Cummin AR Ghiassi R 2003 Changes in brain morphology associated with obstructive sleep apnea. Sleep Med 4 451 454 [31] Gozal E Sachleben LR Jr Rane MJ Vega C Gozal D 2005 Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 288 C535 542 [32] Xu W Chi L Row BW Xu R Ke Y 2004 Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126 313 323 [33] Veasey SC Davis CW Fenik P Zhan G Hsu YJ 2004 Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27 194 201 [34] Pae EK Chien P Harper RM 2005 Intermittent hypoxia damages cerebellar cortex and deep nuclei. Neurosci Lett 375 123 128 [35] Carpenter JS Andrykowski MA 1998 Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45 5 13 [36] Beck A Steer R Brown G 1996 Manual for the Beck Depression Inventory-II. San Antonio, Texas The Psychological Corporation [37] Beck AT Epstein N Brown G Steer RA 1988 An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56 893 897 [38] Beck AT Steer RA Ball R Ranieri W 1996 Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67 588 597 [39] Johns MW 1992 Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15 376 381 [40] Faul F Erdfelder E Lang AG Buchner A 2007 G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 175 191 [41] Arnau RC Meagher MW Norris MP Bramson R 2001 Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 20 112 119 [42] Cross RL Kumar R Macey PM Doering LV Alger JR 2008 Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep 31 1103 1109 [43] Gottlieb DJ Whitney CW Bonekat WH Iber C James GD 1999 Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 159 502 507 [44] Kumar R Macey PM Cross RL Woo MA Yan-Go FL 2009 Neural alterations associated with anxiety symptoms in obstructive sleep apnea syndrome. Depress Anxiety 26 480 491 [45] Harper RM Macey PM Kumar R Woo MA 2009 Neural Injury in Diabetic versus Non-Diabetic Obstructive Sleep Apnea Subjects: a Pilot Study. Sleep 32 A341 [46] Valladares EM Macey PM Kumar R Woo MA Cross RL 2007 Brain structural differences between REM-related and non-REM related obstructive sleep apnea. Soc Neurosci Abs 230.234 [47] Macey PM Woo MA Kumar R Harper RM 2008 Sex-related neural alterations in Obstructive Sleep Apnea. 7th Annual Research and Evidence-Based Practice Conference [48] Lopez-Jimenez F Somers VK 2006 Stress measures linking sleep apnea, hypertension and diabetes–AHI vs arousals vs hypoxemia. Sleep 29 743 744 [49] Veasey SC 2006 Obstructive sleep apnea: re-evaluating our index of severity. Sleep Med 7 5 6 [50] Hossain JL Ahmad P Reinish LW Kayumov L Hossain NK 2005 Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res 14 245 253 [51] Mediano O Barcelo A de la Pena M Gozal D Agusti A 2007 Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 30 110 113 [52] Baguet JP Hammer L Levy P Pierre H Launois S 2005 The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128 3407 3412 [53] Asano K Takata Y Usui Y Shiina K Hashimura Y 2009 New Index for Analysis of Polysomnography, ‘Integrated Area of Desaturation’, Is Associated with High Cardiovascular Risk in Patients with Mild to Moderate Obstructive Sleep Apnea. Respiration [54] Iber C 2007 The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specification. Westchester, IL American Academy for Sleep medicine [55] Backhaus J Junghanns K Broocks A Riemann D Hohagen F 2002 Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 53 737 740 [56] American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV 1994 Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. xxvii Washington, DC American Psychiatric Association 886 p. p [57] 1994 Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition. Washington, DC American Psychiatric Association [58] Lamm J Poeschel J Smith S 2008 Obtaining a thorough sleep history and routinely screening for obstructive sleep apnea. J Am Acad Nurse Pract 20 225 229 [59] Lavie P Herer P Hoffstein V 2000 Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320 479 482